RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression

被引:258
作者
Rezatabar, Setareh [1 ]
Karimian, Ansar [1 ,2 ,3 ]
Rameshknia, Vahid [4 ,5 ]
Parsian, Hadi [1 ]
Majidinia, Maryam [6 ]
Kopi, Tayebeh Azramezani [1 ]
Bishayee, Anupam [7 ]
Sadeghinia, Ali [8 ]
Yousefi, Mehdi [9 ]
Monirialamdari, Mohsen [5 ]
Yousefi, Bahman [10 ,11 ]
机构
[1] Babol Univ Med Sci, Hlth Res Inst, Cellular & Mol Biol Res Ctr, Babol Sar, Iran
[2] Kurdistan Univ Med Sci, Canc & Immunol Res Ctr, Sanandaj, Iran
[3] Babol Univ Med Sci, Student Res Comm, Babol Sar, Iran
[4] Islamic Azad Univ, Tabriz Branch, Fac Med, Tabriz, Iran
[5] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[6] Urmia Univ Med Sci, Solid Tumor Res Ctr, Orumiyeh, Iran
[7] Lake Erie Coll Osteopath Med, Bradenton, FL USA
[8] Tabriz Univ Med Sci, Dept Med Chem, Fac Pharm, Tabriz, Iran
[9] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[10] Tabriz Univ Med Sci, Mol Med Res Ctr, Univ St, Tabriz 5166614766, Iran
[11] Tabriz Univ Med Sci, Dept Clin Biochem & Lab Med, Fac Med, Tabriz, Iran
关键词
DNA damage; DNA repair; ERK; MAPK; reactive oxygen species; cancer; GROWTH-FACTOR RECEPTOR; ACTIVATED PROTEIN-KINASE; HUMAN TUMOR-CELLS; GASTRIC-CANCER; MAP KINASE; IN-VITRO; COLORECTAL-CANCER; ONCOGENIC TRANSFORMATION; MEK/MAPK ACTIVATION; REGULATED KINASES;
D O I
10.1002/jcp.28334
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mitogen-activated protein kinase (MAPK) signaling pathways organize a great constitution network that regulates several physiological processes, like cell growth, differentiation, and apoptotic cell death. Due to the crucial importance of this signaling pathway, dysregulation of the MAPK signaling cascades is involved in the pathogenesis of various human cancer types. Oxidative stress and DNA damage are two important factors which in common lead to carcinogenesis through dysregulation of this signaling pathway. Reactive oxygen species (ROS) are a common subproduct of oxidative energy metabolism and are considered to be a significant physiological modulator of several intracellular signaling pathways including the MAPK pathway. Studies demonstrated that the MAP kinases extracellular signal-regulated kinase (ERK) 1/2 and p38 were activated in response to oxidative stress. In addition, DNA damage is a partly common circumstance in cell life and may result in mutation, cancer, and even cell death. Recently, accumulating evidence illustrated that the MEK/ERK pathway is associated with the suitable performance of cellular DNA damage response (DDR), the main pathway of tumor suppression. During DDR, the MEK/ERK pathway is regularly activated, which contributes to the appropriate activation of DDR checkpoints to inhibit cell division. Therefore, the aim of this review is to comprehensively discuss the critical function of MAPK signaling in oxidative stress, DNA damage, and cancer progression.
引用
收藏
页码:14951 / 14965
页数:15
相关论文
共 95 条
[1]   Ras induces chromosome instability and abrogation of the DNA damage response [J].
Abulaiti, Adili ;
Fikaris, Aphrothiti J. ;
Tsygankova, Oxana M. ;
Meinkoth, Judy L. .
CANCER RESEARCH, 2006, 66 (21) :10505-10512
[2]   Blocking oncogenic Ras signaling for cancer therapy [J].
Adjei, AA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (14) :1062-1074
[3]   p53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints [J].
Agapova, LS ;
Ivanov, AV ;
Sablina, AA ;
Kopnin, PB ;
Sokova, OI ;
Chumakov, PM ;
Kopnin, BP .
ONCOGENE, 1999, 18 (20) :3135-3142
[4]   Oxidative stress activates extracellular signal-regulated kinases through Src and ras in cultured cardiac myocytes of neonatal rats [J].
Aikawa, R ;
Komuro, I ;
Yamazaki, T ;
Zou, YZ ;
Kudoh, S ;
Tanaka, M ;
Shiojima, I ;
Hiroi, Y ;
Yazaki, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (07) :1813-1821
[5]   Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK [J].
Allan, LA ;
Morrice, N ;
Brady, S ;
Magee, G ;
Pathak, S ;
Clarke, PR .
NATURE CELL BIOLOGY, 2003, 5 (07) :647-U45
[6]   Protein kinases as drug targets in cancer [J].
Arslan, Mehmet Alper ;
Kutuk, Ozgur ;
Basaga, Huveyda .
CURRENT CANCER DRUG TARGETS, 2006, 6 (07) :623-634
[7]  
Brown EJ, 2000, GENE DEV, V14, P397
[8]  
Chen TS, 1999, CANCER RES, V59, P213
[9]   Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development [J].
Chung, Eva ;
Kondo, Motonari .
IMMUNOLOGIC RESEARCH, 2011, 49 (1-3) :248-268
[10]   Fighting cancer by disrupting C-terminal methylation of signaling proteins [J].
Clarke, S ;
Tamanoi, F .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (04) :513-515